Hui Zhang

Dr. Hui Zhang


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2016 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
FZFaya Zhang
Faya Zhang
ALAlex Little
Alex Little
HZHui Zhang
Hui Zhang
NK cells are innate immune cells and have important roles in antiviral and antitumor immunity. Based on the transcriptional regulation, organ distribution, and cell function, NK cells have recently been further divided into cytotoxic conventional NK cells (cNK) and noncytotoxic helper-like group 1 innate lymphoid cells (ILC1s). It is well known that chronic alcohol consumption decreases peripheral NK cell number and cytolytic activity; however, the underlying mechanism remains to be elucidated. How chronic alcohol consumption affects ILC1s is, to our knowledge, completely unexplored. Herein, we used a well-established mouse model of chronic alcohol consumption to study the effects of alcohol on transcription factor expression, maturation, and cytokine production of cNK cells and ILC1s in various organs. We found that alcohol consumption significantly decreased Eomes-expressing cNK cells in all the examined organs, except BM, but did not significantly affect ILC1s. Alcohol consumption compromised cNK cell development and maturation. Exogenous IL-15/IL-15Rα treatment caused full recovery of Eomes-expressing cNK cell number and maturation. Taken together, our data indicated that chronic alcohol consumption decreases cNK cell number and cytolytic activity by arresting cNK cell development at the CD27+CD11b+ stage. This developmental arrest of NK cells results from a lack of IL-15 availability in the microenvironment. IL-15/IL-15Rα treatment can recover alcohol consumption-induced developmental defect in NK cells.

18 May 2022 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
HZHui Zhang
Hui Zhang
ZZZhaohui Zhu
Zhaohui Zhu
SMSamantha Modrak
Samantha Modrak
ALAlexander Little
Alexander Little
Tumor immunology has been studied extensively. Tumor immunology–based cancer immunotherapy has become one of the most promising approaches for cancer treatment. However, one of the fundamental aspects of tumor immunology—the initiation of antitumor immunity—is not fully understood. Compared to that of CD8+ T cells, the effect of CD4+ T cells on antitumor immunity has not been fully appreciated. Using a gene knockout mouse model, the mice of which are deficient in the TCRα repertoire, specifically lacking invariant NKT and mucosal-associated invariant T cells, we found that the deficiency in TCRα repertoire diversity did not affect the antitumor immunity, at least to B16BL6 melanoma and EO771 breast cancer. However, after acquiring thymocytes or splenocytes from wild-type mice, these knockout mice exhibited greatly enhanced and long-lasting antitumor immunity. This enhanced antitumor immunity depended on CD4+ T cells, especially CD4+ tissue-resident memory T (TRM) cells, but not invariant NKT or CD8+ T cells. We also present evidence that CD4+ TRM cells initiate antitumor immunity through IFN-γ, and the process is dependent on NK cells. The CD4+ TRM/NK axis appears to control tumor formation and development by eliminating tumor cells and modulating the tumor microenvironment. Taken together, our results demonstrated that CD4+ TRM cells play a dominant role in the initiation of antitumor immunity.

11 November 2019 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
YLYuanfei Li
Yuanfei Li
FZFaya Zhang
Faya Zhang
SMSamantha Modrak
Samantha Modrak
ALAlex Little
Alex Little
HZHui Zhang
Hui Zhang

1 January 2015 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
HZHui Zhang
Hui Zhang
FZFaya Zhang
Faya Zhang
ZZZhaohui Zhu
Zhaohui Zhu
DLDung Luong
Dung Luong
GMGary G. Meadows
Gary G. Meadows

1 August 2012 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
HZHui Zhang
Hui Zhang
ZZZhaohui Zhu
Zhaohui Zhu
GMGary G. Meadows
Gary G. Meadows
Accumulating research indicates that B cells are involved in anti-tumor immunity. Chronic alcohol consumption is associated with decreased survival of cancer patients. The effect of alcohol consumption on B cells in tumor-bearing hosts is unknown. Results in melanoma-bearing mice showed that chronic alcohol consumption did not alter the percentage and number of B cells in bone marrow, spleen, and lymph nodes but dramatically decreased B cells in the peripheral blood. Alcohol consumption did not alter the development of B cells in the bone marrow and did not affect follicular B cells in the spleen; however, it increased T1 B cells and decreased marginal zone B cells in the spleen. Alcohol consumption also decreased mature B cells in the blood. It did not alter the chemotactic capacity of plasma to facilitate migration of splenocytes or the chemotactic response of splenocytes to CXCL13 and CCL21. However, the response of splenocytes to sphingosine-1-phosphate was impaired in alcohol-consuming, melanoma-bearing mice. The expression of sphingosine-1-phosphate receptor-1 (S1PR1) and sphingosine-1-phosphate lyase-1 (SPL1) in splenocytes was downregulated. Taken together, these results indicate that chronic alcohol consumption decreases peripheral blood B cells by compromising B cell egress from the spleen. The downregulation of S1PR1 and SPL1 expression in alcohol-consuming, melanoma-bearing mice could be associated with compromised egress of B cells from the spleen.

10 November 2014
Verified
Book Chapter
Closed access
PDF file
HZHui Zhang
Hui Zhang
ZZZhaohui Zhu
Zhaohui Zhu
FZFaya Zhang
Faya Zhang
GMGary G. Meadows
Gary G. Meadows